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Hemoglobinopathies are disorders of the hemoglobin chain synthesis. They fall into two broad categories: quantitative disorders (thalassemia syndromes) and qualitative disorders (structural hemoglobin variants). The structural hemoglobin variants are due to altered amino acid sequence in the The clinical condition due to the unstable hemoglobin Wien (Hb Wien) was first reported in a young Austrian man, and his daughter in 1964. 4 The identified hemoglobin represents a β -chain variant named Hb Wien by Kleihauer et al. 5 Subsequent laboratory studies characterized its structure and properties. [6] [7] [8] The available knowledge about Hb Wien and the resulting disease was derived from the first identified patient and his daughter. [4] [5] [6] [7] [8] [9] This paper summarizes the clinical and laboratory findings in all four patients of the largest known Hb Wien pedigree and adds information on disease severity and long-term course.
The index case, an 11 months old girl, was referred for further workup of severe anemia (hemoglobin 7 g/dl) diagnosed in the setting of a febrile illness.
The child was born at term after an inconspicuous first pregnancy of the mother.
During the first days of life, there was a mild hyperbilirubinemia, which did not require treatment. The child's growth and motor development until referral were ageappropriate. On physical examination, the child was in a good general condition; the skin and the eyes were not jaundiced, and the liver and the spleen were not palpable.
Family history: The father of the child (Pedigree III.2), as well as the father´s mother (Pedigree II.1) and grandfather (Pedigree I.1) are known to have hemolytic anemia due to the unstable Hb Wien. The two cases of Hb Wien published by Braunsteiner et al. 4 are grandmother and great-grandfather of the referred child (Figure 1) .
The laboratory values of the index case, the father and the grandmother performed at the first referral of the child are summarized in Table 1 .
Hemoglobin studies were performed by alkaline agarose gel electrophoresis (run semi-automatically on a Sebia HYDRASYS 2 SCAN ) and HPLC (BIO-RAD VARIANT II Hemoglobin testing System in Beta-Thal-Mode). The results of the HPLC are presented in Table 2 The grandmother (Pedigree II.1) is now 60 years old. Her average hemoglobin is in the range of 8.0-9.0 g/dl. She has received a total of six packed red cell transfusions (two for surgery and each two during the two pregnancies). She had one ERCP for gall sludge but has had no cholecystectomy yet. Her spleen is palpable at 4-5 cm below the costal margin. MRI assessment for iron overload was deferred for lack of consent.
The great-grandfather (Pedigree I.1) was splenectomized at the age of 16 years. 4 Afterwards, he was reported to have thrombocytosis and recurrent thromboembolic episodes 9 and died on pulmonary embolic event at the age of 49 years.
Hemoglobin Wien is an unstable hemoglobin variant, caused by the amino acid substitution ß130(H8) Tyr-Asp at the base of the heme pocket. 6 It causes mild to moderate microcytic, hypochromic anemia with elevated reticulocyte counts and biochemical signs of hemolysis (Table 1) . A recently published case had similar features. 3 Inclusion bodies (Heinz bodies) are present in 1-2% of the red blood cells before splenectomy, but after spleen removal, they raise to 30-40%.
Potentially misleading hemoglobin electrophoresis is one of the major challenges of correctly diagnosing unstable hemoglobins. 3 Unstable hemoglobins can be missed either due to migration properties indistinguishable from Hb A 1 or due to their rapid degradation. In cationic HPLC, Hb Wien does not separate from Hb A 0 (Suppl. Figure   1 ).
In alkaline agarose gel electrophoresis Hb Wien and Hb A 1 overlap (Suppl. Figure 2) , while in polyacrylamide disc electrophoresis Hb Wien migrates somewhat faster and can be clearly separated from Hb A 1, as reported previously. 10 Previously reported quantitative separation revealed HbA 1 70.4%, Hb Wien 24.2%, HbA 2 2.5% and HbF 2.9%. 5 Hb Wien quantification at 24% is most probably due to its instability. Further characteristics of Hb Wien are an almost normal methemoglobin formation, slightly higher susceptibility to spontaneous oxidation and heat instability at 50°C, as well as an increased osmotic fragility. 4, 5, 7 Unlike β -thalassemia, Hb Wien is not associated with ineffective erythropoiesis. 7, 9 Neither the bone marrow examination in I.1 and the nuclide scan findings in I.1 and II.1, nor the clinical follow-up of the patients have revealed signs of extramedullary erythropoiesis. 7, 9 The original report of the first patient (Pedigree I.1) stated that the condition of the patient worsened at the age of 16 years, and repeated transfusions were necessary. 4 However, this report stays in contradiction to our observation of the other three family members, who have compensated hemolysis and relatively stable hemoglobin levels.
Similarly to other chronic hemolytic anemias, Hb Wien is also associated with a risk for developing gallstones. This complication in patient III.2, who underwent cholecystectomy for symptomatic gallstones at the age of 20 years, was possibly accelerated by a coinheritance of Gilbert syndrome.
Patients with chronic hemolysis may be at risk for developing iron overload over time.
The two members of the Hb Wien pedigree (II.1 and III.2), who have been followed for more than thirty years, still have a transferrin saturation within the normal range (Table   1 ). The lack of iron overload in patient III.2 was documented by MRI assessment of the heart and the liver.
Both II.1 and III.2 have developed significant splenomegaly yet without any signs of hypersplenism. The youngest patient (IV.2) does not have a palpable spleen, possibly due to the still very young age.
In the 1960-70s splenectomy was considered an effective therapeutic option for hereditary hemolytic anemias. Over time, it became clear that splenectomy is not effective in all conditions presenting with chronic hemolytic anemia. On the other hand, the resulting asplenia may lead to severe complications. An expert panel has recently issued recommendations regarding splenectomy in hereditary hemolytic anemias. 11 The experts agree that splenectomy should only be considered for patients with unstable hemoglobin who have severe anemia and/or massive or symptomatic splenomegaly. The disease course in patient I.1, who has been splenectomized at the age of 16 years corroborates those recommendations. The effect of the splenectomy seems to have been equivocal, as the original paper reported on improvement 4 , while a subsequent report stated that splenectomy did not significantly influence anemia. 9 Moreover, the latter paper, which reported on ferrokinetic and erythrokinetic nuclide scan findings in the patient and his daughter concluded that spleen does not play any appreciable role in this condition. 9 Based on the observation of the largest affected pedigree to date, we conclude that Hb Wien is a very rare unstable hemoglobin variant with an autosomal-dominant inheritance pattern, resulting in chronic non-transfusion-dependent microcytic hemolytic anemia. Splenectomy is of equivocal effectiveness in this condition and should be avoided given the increased risk for thrombotic complications. P3: posttranslationally modified hemoglobin
